Hammer, Gary D.

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell

Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer

Cited by 3,201

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism

Adrenal Hormones and DisordersHormonal Regulation and Hypertension

Cited by 1,769

Adrenocortical carcinoma

Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 892

Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.

Nachtigal, M. W., Hirokawa, Y., Enyeart-VanHouten, D. L., Flanagan, J. N., Hammer, G. D., & Ingraham, H. A. (1998) · Cell

Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and Disorders

Cited by 591

Management of patients with adrenal cancer: recommendations of an international consensus conference

Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 421

Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling

Giordano, T. J., Kuick, R., Else, T., Gauger, P. G., Vinco, M., Bauersfeld, J., Sanders, D., Thomas, D. G., Doherty, G., & Hammer, G. (2009) · Clinical Cancer Research

Adrenal and Paraganglionic TumorsBreast Cancer Treatment Studies

Cited by 401

Phosphorylation of the Nuclear Receptor SF-1 Modulates Cofactor Recruitment

Hammer, G. D., Krylova, I., Zhang, Y., Darimont, B. D., Simpson, K., Weigel, N. L., & Ingraham, H. A. (1999) · Molecular Cell

Estrogen and related hormone effectsNuclear Receptors and Signaling

Cited by 375

Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma

Miller, B. S., Ammori, J. B., Gauger, P. G., Broome, J. T., Hammer, G. D., & Doherty, G. M. (2010) · World Journal of Surgery

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 221

Adrenocortical carcinoma is a Lynch syndrome-associated cancer

Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology

Genetic factors in colorectal cancerAdrenal and Paraganglionic Tumors

Cited by 208

Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex

Kim, A. C., Reuter, A. L., Zubair, M., Else, T., Serecky, K., Bingham, N. C., Lavery, G. G., Parker, K. L., & Hammer, G. D. (2008) · Development

Wnt/β-catenin signaling in development and cancerDevelopmental Biology and Gene Regulation

Cited by 202

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., Paccagnella, M. L., de Bono, J. S., Gualberto, A., & Hammer, G. D. (2010) · Cancer Chemotherapy and Pharmacology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 197

Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma

Barlaskar, F. M., Spalding, A. C., Heaton, J. H., Kuick, R., Kim, A. C., Thomas, D. G., Giordano, T. J., Ben-Josef, E., & Hammer, G. D. (2009) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsGrowth Hormone and Insulin-like Growth Factors

Cited by 189

Development of adrenal cortex zonation

Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America

Adrenal Hormones and DisordersHormonal Regulation and Hypertension

Cited by 174

Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin

Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology

Adrenal and Paraganglionic TumorsChromatin Remodeling and Cancer

Cited by 173

Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy

Miller, B. S., Gauger, P. G., Hammer, G. D., & Doherty, G. M. (2012) · Surgery

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 153

Adjuvant and definitive radiotherapy for adrenocortical carcinoma

Sabolch, A., Feng, M., Griffith, K., Hammer, G., Doherty, G., & Ben-Josef, E. (2011) · International Journal of Radiation Oncology*Biology*Physics

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 115

Reciprocal Regulation of a Glucocorticoid Receptor-Steroidogenic Factor-1 Transcription Complex on the Dax-1 Promoter by Glucocorticoids and Adrenocorticotropic Hormone in the Adrenal Cortex

Gummow, B. M., Scheys, J. O., Cancelli, V. R., & Hammer, G. D. (2006) · Molecular Endocrinology

Adrenal Hormones and DisordersEstrogen and related hormone effects

Cited by 114

Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma

Raymond, V. M., Else, T., Everett, J. N., Long, J. M., Gruber, S. B., & Hammer, G. D. (2013) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsBRCA gene mutations in cancer

Cited by 105

Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency

Auchus, R. J., Buschur, E. O., Chang, A. Y., Hammer, G. D., Ramm, C., Madrigal, D., Wang, G., Gonzalez, M., Xu, X. S., Smit, J. W., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 97

ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs

LaPensee, C. R., Mann, J. E., Rainey, W. E., Crudo, V., Hunt, S. W., & Hammer, G. D. (2016) · Endocrinology

Cancer, Lipids, and MetabolismCholesterol and Lipid Metabolism

Cited by 86

Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade

Miller, B. S., Gauger, P. G., Hammer, G. D., Giordano, T. J., & Doherty, G. M. (2010) · Langenbeck s Archives of Surgery

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 84

Adrenocorticotropic Hormone-Mediated Signaling Cascades Coordinate a Cyclic Pattern of Steroidogenic Factor 1-Dependent Transcriptional Activation

Winnay, J. N., & Hammer, G. D. (2006) · Molecular Endocrinology

Adrenal Hormones and DisordersEstrogen and related hormone effects

Cited by 74

Urogenital and caudal dysgenesis in adrenocortical dysplasia ( acd ) mice is caused by a splicing mutation in a novel telomeric regulator

Keegan, C. E., Hutz, J. E., Else, T., Adamska, M., Shah, S. P., Kent, A. E., Howes, J. M., Beamer, W. G., & Hammer, G. D. (2005) · Human Molecular Genetics

Developmental Biology and Gene RegulationCongenital limb and hand anomalies

Cited by 68

Molecular mechanisms of stem/progenitor cell maintenance in the adrenal cortex

Lerario, A. M., Finco, I., LaPensee, C., & Hammer, G. D. (2017) · Frontiers in Endocrinology

Adrenal Hormones and DisordersDevelopmental Biology and Gene Regulation

Cited by 68